CRISPR-Based Gene Editing Market Report 2024-2030, Featuring Revvity, Danaher, Genscript, Merck, Tocris Bioscience, Origene Technologies, Bio-Rad Laboratories, Bio-Techne & New England Biolabs

(MENAFN- GlobeNewsWire - Nasdaq) Dublin, Oct. 21, 2024 (GLOBE NEWSWIRE) -- The "CRISPR-based Gene Editing Market Size, Share and Trends Analysis Report by Product & Service (CRISPR Kits & Reagents), Application (Biomedical, Agricultural), End-use, and Region 2024-2030" report has been added to ResearchAndMarkets.com's offering.
The global CRISPR-based gene editing market size is anticipated to reach USD 9.14 billion by 2030 and is projected to grow at a CAGR of 14.73% from 2024 to 2030.

This robust growth trajectory in the market is driven by several key factors, including the rising prevalence of genetic disorders, significant advancements in CRISPR technology, supportive regulatory frameworks, and increasing investments in biotechnology and healthcare research. Together, these elements create a dynamic environment for innovation and development.

Advancements in CRISPR technology have notably fueled market expansion. Researchers have made remarkable progress in developing more precise and efficient CRISPR systems, including CRISPR/Cas9, CRISPR/Cas12, and emerging base editing technologies. These innovations have broadened the scope of potential applications, extending from treating genetic disorders to formulating targeted therapies for various cancers and infectious diseases. The enhanced ability to edit genes with high specificity and minimal off-target effects has captured considerable interest from both pharmaceutical and biotechnology sectors, which are increasingly eager to leverage these groundbreaking technologies for therapeutic development.
Moreover, the growing emphasis on personalized medicine is significantly influencing the demand for CRISPR technologies. As the healthcare landscape shifts toward more individualized treatment approaches, the capability to edit genes with precision enables the creation of therapies tailored to the unique genetic profiles of patients. This paradigm shift in medicine is likely to further accelerate the adoption of CRISPR technologies, as they provide unparalleled opportunities to develop targeted and effective treatments that can dramatically improve patient outcomes.
Supportive regulatory frameworks are fostering a conducive environment for research and commercialization. Regulatory bodies are increasingly recognizing the potential of CRISPR technologies, leading to streamlined approval processes that encourage innovation. Overall, the confluence of these factors positions the market for continued growth and innovation in the coming years, paving the way for revolutionary advancements in healthcare and biotechnology.
CRISPR-based Gene Editing Market Report Highlights

• The products segment, which includes CRISPR kits and reagents, CRISPR libraries, and other related tools, led the market with the largest revenue share of 73.96% in 2023
• Based on application, the biomedical segment led the market with the largest revenue share of 81.83% in 2023 and is also projected to witness at the fastest CAGR of 15.09% during the forecast period. This growth is fueled by several key drivers, including the increasing prevalence of genetic disorders and cancers, alongside significant advancements in CRISPR technology
• Based on end use, the pharmaceutical & biotechnology companies segment led the market with the largest revenue share of 46.31% in 2023

The leading players in the CRISPR-based Gene Editing market include:

• Revvity
• Danaher
• GenScript
• Merck
• Thermo Fisher Scientific
• Tocris Bioscience
• OriGene Technologies
• Bio-Rad Laboratories
• Bio-Techne
• New England Biolabs

This report addresses:

• Market intelligence to enable effective decision-making
• Market estimates and forecasts from 2018 to 2030
• Growth opportunities and trend analyses
• Segment and regional revenue forecasts for market assessment
• Competition strategy and market share analysis
• Product innovation listing for you to stay ahead of the curve

Key Attributes:

Report Attribute	Details
No. of Pages	120
Forecast Period	2023 - 2030
Estimated Market Value (USD) in 2023	$3.58 Billion
Forecasted Market Value (USD) by 2030	$9.14 Billion
Compound Annual Growth Rate	14.7%
Regions Covered	Global

Key Topics Covered:
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. CRISPR-based Gene Editing Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Increasing prevalence of genetic disorders
3.2.1.2. Growing investments in biotechnology and healthcare research
3.2.1.3. Advancements in CRISPR technology and applications
3.2.2. Market restraint analysis
3.2.2.1. Ethical concerns surrounding gene editing
3.2.2.2. High costs associated with CRISPR research and development
3.3. CRISPR-based Gene Editing Market Analysis Tools
Chapter 4. CRISPR-based Gene Editing Market: Product & Service Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Global CRISPR-based Gene Editing Market Product & Service Movement Analysis
4.3. Global CRISPR-based Gene Editing Market Size & Trend Analysis, by Product & Service, 2018 to 2030 (USD Million)
4.4. Products
4.4.1. Products market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.2. CRISPR Kits & Reagents
4.4.3. CRISPR Libraries
4.4.4. Others
4.5. Services
Chapter 5. CRISPR-based Gene Editing Market: Application Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Global CRISPR-based Gene Editing Market Application Movement Analysis
5.3. Global CRISPR-based Gene Editing Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
5.4. Biomedical
5.4.2. Therapeutic Development
5.4.2.1. Therapeutic development market estimates and forecasts, 2018 to 2030 (USD Million)
5.4.2.2. By Indication
5.4.2.2.1. Genetic Disorders
5.4.2.2.2. Oncology
5.4.2.2.3. Ophthalmology
5.4.2.2.4. Others
5.4.2.3. By Delivery Method
5.4.2.3.1. Ex Vivo
5.4.2.3.3. In Vivo
5.4.3. Disease Diagnostics
5.5. Agricultural applications
5.5.2. Plant Engineering
5.5.3. Farm Animals Engineering
5.5.4. Others
Chapter 6. CRISPR-based Gene Editing Market: End-use Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Global CRISPR-based Gene Editing Market End-use Movement Analysis
6.3. Global CRISPR-based Gene Editing Market Size & Trend Analysis, by End-use, 2018 to 2030 (USD Million)
6.4. Pharmaceutical & Biotechnology Companies
6.5. Academic & Research Institutes
6.6. Contract Research Organizations
Chapter 7. CRISPR-based Gene Editing Market: Regional Estimates & Trend Analysis
7.1. Regional Market Share Analysis, 2023 & 2030
7.2. Regional Market Dashboard
7.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030
Chapter 8. Competitive Landscape
8.1. Company/Competition Categorization
8.2. Strategy Mapping
8.3. Company Market Position Analysis, 2023
8.4. List of Key Buyers for CRISPR-based Gene Editing Products & Services
8.5. Company Profiles/Listing

• Revvity, Inc.
• Danaher
• GenScript
• Merck KGaA
• Thermo Fisher Scientific, Inc.
• Tocris Bioscience
• OriGene Technologies, Inc.
• Bio-Rad Laboratories
• Bio-Techne
• New England Biolabs, Inc.

For more information about this report visit

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Attachment

• CRISPR-based Gene Editing Market

CONTACT: CONTACT: Laura Wood,Senior Press Manager ... For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

MENAFN21102024004107003653ID1108802529